Clinical features of type 1 autoimmune hepatitis in adolescence and early adulthood

Hepatology Research

Volumn 39, Issue 8, 2009, Pages 766-771

  Miyake, Yasuhiro ^a   Iwasaki, Yoshiaki ^a   Kobashi, Haruhiko ^a   Yasunaka, Tetsuya ^a   Ikeda, Fusao ^a   Takaki, Akinobu ^a   Okamoto, Ryoichi ^a   Takaguchi, Kouichi ^a   Ikeda, Hiroshi ^a   Makino, Yasuhiro ^a   Sakaguchi, Kohsaku ^a   Ando, Masaharu ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Acute hepatitis; Autoimmune hepatitis; Autoimmune thyroiditis; Human leukocyte antigen

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G; PREDNISOLONE; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; AUTOIMMUNE HEPATITIS TYPE 1; AUTOIMMUNE THYROIDITIS; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENETIC ASSOCIATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; TREATMENT RESPONSE;

EID: 68349133392     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00510.x     Document Type: Article

References (25)

1. Czaja AJ, Freese DK, American Association for the Study of Liver Disease. Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002; 36: 479-97.
2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
3. Czaja AJ, Souto EO, Bittencourt PL etal. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J Hepatol 2002; 37: 302-8.
4. Al-Chalabi T, Underhill JA, Portmann BC, McFarlane IG, Heneghan MA. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008; 48: 140-7.
5. Czaja AJ, Carpenter HA. Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly. Hepatology 2006; 43: 532-8.
6. Toda G, Zeniya M, Watanabe F etal. Present status of autoimmune hepatitis in Japan -correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 1997; 26: 1207-12.
7. Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: A systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006; 45: 575-83.
8. Czaja AJ, Donaldson PT. Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis. Immunol Rev 2000; 174: 250-9.
9. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
10. Vitali C, Bombardieri S, Jonsson R et al., European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
12. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
13. Gregorio GV, Portmann B, Reid F et al. Autoimmune hepatitis in childhood: A 20-year experience. Hepatology 1997; 25: 541-7.
14. Oettinger R, Brunnberg A, Gerner P, Wintermeyer P, Jenke A, Wirth S. Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis. J Autoimmun 2005; 24: 79-84.
15. Zeitlin AA, Heward JM, Newby PR et al. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease. Genes Immun 2008; 9: 358-63.
16. Honda K, Tamai H, Morita T, Kuma K, Nishimura Y, Sasazuki T. Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 1989; 69: 1268-73.
17. Czaja AJ, Carpenter HA. Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis. J Hepatol 2004; 40: 646-52.
18. Maggiore G, Veber F, Bernard O et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993; 17: 376-81.
19. Saadah OI, Smith AL, Hardikar W. Long-term outcome of autoimmune hepatitis in children. J Gastroenterol Hepatol 2001; 16: 1297-302.
20. Abe M, Hiasa Y, Masumoto T et al. Clinical characteristics of autoimmune hepatitis with histological features of acute hepatitis. Hepatol Res 2001; 21: 213-19.
21. Iwai M, Jo M, Ishii M, Mori T, Harada Y. Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis. Hepatol Res 2008; 38: 784-9.
22. Agarwal K, Czaja AJ, Jones DE, Donaldson PT. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31: 49-53.
23. Okumura A, Ishikawa T, Sato S et al. Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4CD25 T cells in patients with autoimmune hepatitis. Hepatol Res 2008; 38: 896-903.
24. Kido M, Watanabe N, Okazaki T etal. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology 2008; 135: 1333-43.
25. Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Petersen GM, Lazaridis KN. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. Hepatology 2008; 47: 563-70.